drug-shortages
(2)
Shorla Oncology
Shorla Oncology is a specialty pharmaceutical company based in Clonmel, Ireland, with a U.S. base in Cambridge, Massachusetts, that develops and commercializes innovative oncology drugs for orphan and pediatric cancers. Founded in 2018 by Sharon Cunningham and Orlaith Ryan, Shorla focuses on indications where existing treatments are limited, in shortage, or poorly suited to patients - reformulating and reinventing cancer therapies into easier-to-administer forms such as oral liquids and ready-to-dilute vials. The company markets four FDA-approved products in the U.S. and is advancing an early-stage pipeline addressing rare cancers.
Antheia, Inc.
Antheia is a Menlo Park biotech using engineered yeast to brew the active ingredients behind essential medicines - replacing slow, weather-dependent poppy farming with industrial-scale fermentation. Founded out of Stanford's Smolke Lab, the company aims to end pharmaceutical shortages by turning sugar into complex molecules like thebaine in weeks instead of years.